Veracyte, inc. (VCYT)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13
Operating activities
Net loss

-22,398

-12,599

-8,246

-11,985

-15,739

-22,999

-28,333

-30,913

-31,963

-31,003

-26,967

-25,555

-29,500

-31,358

-34,968

-38,276

-36,169

-33,704

-33,833

-32,790

-30,309

-29,373

-27,123

-25,524

-25,359

-25,580

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

5,144

4,117

3,806

3,820

3,885

3,920

3,952

3,964

3,919

3,841

3,748

3,654

3,651

3,511

3,214

2,961

2,664

2,254

1,984

1,630

1,263

1,175

1,115

1,112

1,066

999

0

0

0

Gain on disposal of property and equipment

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Bad debt expense

-

-

-

-

-

-

-

-

-

-

-

-

-

68

93

119

149

105

67

69

48

54

-8

31

44

109

0

0

0

Genzyme co-promotion fee amortization

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,422

1,669

1,853

1,897

1,898

1,968

2,118

2,269

2,419

2,500

2,500

2,500

0

0

0

Stock-based compensation

10,953

9,807

8,498

7,377

6,542

5,958

6,217

6,309

6,220

6,617

6,458

6,419

6,454

6,378

6,161

6,063

5,875

5,602

5,332

4,893

4,279

3,548

2,798

2,125

1,535

1,247

0

0

0

Other income

-

-

-

-

-

-93

-93

-93

-93

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of debt issuance costs

75

83

91

99

32

32

417

435

454

472

106

107

107

173

158

142

127

46

50

66

82

97

0

0

0

-

-

-

-

Interest on end-of-term debt obligation

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

80

80

80

81

0

0

0

-

-

-

-

Write-down of excess supplies

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Noncash lease expense

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revaluation of acquisition-related contingent consideration

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in value of preferred stock liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,070

0

0

0

Changes in operating assets and liabilities:
Accounts receivable

2,476

6,161

11,351

6,620

3,417

452

627

1,979

4,073

3,960

5,323

7,640

5,897

5,321

2,885

-79

817

558

2,407

2,224

1,419

1,961

458

470

771

683

0

0

0

Supplies

3,414

3,404

3,145

2,055

-789

-1,922

-297

-268

1,114

1,849

344

-185

-209

-292

-568

-473

-80

71

634

675

1,011

1,129

1,958

2,530

1,984

1,517

0

0

0

Prepaid expenses and other current assets

653

-154

393

807

289

517

186

-66

2

7

212

437

483

415

-2,219

-700

-90

-304

1,364

480

463

38

-909

-17

115

722

0

0

0

Operating lease liability

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

253

351

391

463

583

760

659

464

339

192

-25

-38

-81

-25

33

16

62

42

53

74

72

46

54

15

-7

-24

0

0

0

Accounts payable

3,583

-141

3,573

2,090

668

-1,568

-1,799

-450

690

1,728

-163

-370

-1,214

-1,441

-2,102

286

-2,889

-3,546

-3,255

-6,140

-527

1,874

2,833

6,690

5,580

3,348

0

0

0

Accrued liabilities

1,291

5,228

1,148

1,976

783

724

872

-324

1,388

-1,163

341

-1,033

-759

451

1,794

5,744

5,843

4,463

3,360

2,312

425

355

1,672

-412

1,902

3,862

0

0

0

Net cash used in operating activities

-7,522

-3,232

-6,248

-6,475

-7,119

-13,521

-18,111

-21,431

-23,242

-23,915

-22,331

-24,666

-27,470

-27,982

-26,580

-22,944

-26,696

-26,965

-32,571

-35,301

-29,742

-27,632

-22,494

-21,200

-19,297

-19,159

0

0

0

Investing activities
Purchases of property and equipment

2,656

2,756

2,110

2,537

2,412

1,874

1,720

1,788

1,367

1,755

1,905

1,351

1,970

4,210

7,950

8,900

8,509

6,165

2,508

1,972

2,411

2,024

1,762

1,295

900

1,332

0

0

0

Proceeds from disposal of property and equipment

7

23

23

17

16

0

0

0

0

440

440

440

440

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Change in restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2

2

723

533

0

0

0

-

-

-

-

-50

0

0

0

Net cash used in investing activities

-42,649

-42,733

-2,087

-2,520

-2,396

-1,874

-1,720

-1,788

-1,367

-1,315

-1,463

-909

-1,410

-4,210

-7,952

-8,902

-9,232

-6,698

-3,041

-9,491

-9,327

-9,010

-8,748

-1,295

-900

-1,282

0

0

0

Financing activities
Proceeds from the issuance of common stock in a public offering, net of costs

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from the issuance of long-term debt, net of debt issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

24,452

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Payment of convertible preferred stock issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Payment of deferred stock offering costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

Payment of long-term debt

12,400

24,900

24,900

24,900

12,500

0

0

0

0

-

-

-

-

5,000

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Payment of end-of-term debt obligation and prepayment penalty

-

-

-

-

-

-

-

-

-

-

-

-

-

288

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from legal settlement regarding short-swing profits

-

-

-

-

-

403

403

403

403

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payment of taxes on vested restricted stock units

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payment of financial lease liability

233

308

304

300

296

292

287

283

279

274

204

135

66

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from the exercise of common stock options and employee stock purchases

11,995

14,647

13,508

10,198

8,518

4,350

3,368

2,315

2,052

1,897

1,227

1,033

997

1,216

1,001

877

1,263

722

775

691

740

675

662

707

332

552

0

0

0

Net cash used in financing activities

135,462

127,287

126,151

177,884

50,204

59,499

56,482

394

135

-218

33,172

33,047

32,932

52,329

20,115

19,794

57,586

37,733

37,726

37,839

630

436

59,818

59,810

77,362

77,659

0

0

0

Supplementary cash flow information of non-cash investing and financing activities:
Operating lease liability arising from obtaining right-of-use assets - operating lease at beginning of period

-

-

-

-

-

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Supplementary cash flow information:
Purchases of property and equipment included in accounts payable and accrued liability

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

Interest paid on debt

105

332

642

1,125

1,419

1,547

1,635

1,919

2,304

2,718

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net decrease in cash, cash equivalents and restricted cash

85,291

81,322

117,816

168,889

40,689

44,104

36,651

-22,825

-24,474

-25,448

9,378

7,472

4,052

20,137

-14,417

-12,052

21,658

4,070

2,114

-6,953

-38,439

-36,206

28,576

37,315

57,165

57,218

0

0

0

Unpaid deferred stock offering

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-